Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot"
about
In silico screening of mutational effects on enzyme-proteic inhibitor affinity: a docking-based approachSpecificity and cooperativity at β-lactamase position 104 in TEM-1/BLIP and SHV-1/BLIP interactionsCrystal structures of murine angiogenin-2 and -3 - probing ‘structure - function’ relationships amongst angiogenin homologuesFunctional Evolution of Ribonuclease Inhibitor: Insights from Birds and ReptilesRibonuclease inhibitor: structure and functionThe modular organization of domain structures: insights into protein-protein bindingFundamental aspects of protein-protein association kineticsAngiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway.Selective abolition of pancreatic RNase binding to its inhibitor protein.Rate theories for biologistsEvasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicityLeukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.Volume-based solvation models out-perform area-based models in combined studies of wild-type and mutated protein-protein interfaces.A new scoring function for protein-protein docking that identifies native structures with unprecedented accuracy.KFERQ sequence in ribonuclease A-mediated cytotoxicity.Dissecting cooperative and additive binding energetics in the affinity maturation pathway of a protein-protein interface.Are hot-spots occluded from water?Immune Modulation by Human Secreted RNases at the Extracellular Space.
P2860
Q24678312-9AF56D85-7CA1-4FE7-932F-26A58F3DD312Q27666846-695EEAED-DF18-48FA-96B6-4108EAC2EBC5Q27675196-990A9C23-FFFA-48CA-BC25-AA804EBE4B41Q27684378-DE23406C-5861-42DF-8938-E311E0D8E2F4Q28272410-5B5F8B1A-C96F-4FAE-BCA3-FA0BE1326C6EQ28471819-6141E493-7116-4144-96EB-BC568A5C5440Q33893739-40616D8A-48AF-4B48-9AC8-268EEB0FFFBAQ35050128-CBF75ACD-D2FB-4C0D-917F-B6DC301E6232Q35121165-EB7548CE-B5B4-4C0D-9184-06599404061EQ36520904-7E4BF568-1B8E-441F-90F7-C33AC88318C0Q37233080-FEAA41F7-DEB1-4095-858A-2FE95990715AQ40653268-154EABDB-7CEC-4833-B3B1-A64EDD17D48BQ41188969-876D2CD4-F0E8-412C-9012-471CED91BFE1Q41711426-F3BA813A-65C9-409D-AFD0-65B7F7383722Q43860699-33DD7816-4F9F-475B-A0FC-C0762F0B216AQ44599850-00EF1B8F-A181-4687-A3C6-184E8254D52BQ45926975-CEDF1436-F576-4FD6-82E0-F66B5BE44DF6Q55255353-1B0D7BA3-E271-4B1F-AE37-AD7757E5FDAE
P2860
Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot"
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Analysis of the interactions o ...... side the C-terminal "hot spot"
@ast
Analysis of the interactions o ...... side the C-terminal "hot spot"
@en
Analysis of the interactions o ...... side the C-terminal "hot spot"
@nl
type
label
Analysis of the interactions o ...... side the C-terminal "hot spot"
@ast
Analysis of the interactions o ...... side the C-terminal "hot spot"
@en
Analysis of the interactions o ...... side the C-terminal "hot spot"
@nl
prefLabel
Analysis of the interactions o ...... side the C-terminal "hot spot"
@ast
Analysis of the interactions o ...... side the C-terminal "hot spot"
@en
Analysis of the interactions o ...... side the C-terminal "hot spot"
@nl
P2093
P356
P1476
Analysis of the interactions o ...... side the C-terminal "hot spot"
@en
P2093
M Ruiz-Gutierrez
P304
P356
10.1006/JMBI.2000.4075
P407
P577
2000-09-15T00:00:00Z